MedTrace Logo

Epigenetics Modifications in Obstructive Sleep Apnea

NCT02131610 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2014-05-06

No results posted yet for this study

Summary

Changes in epigenetic regulation of genes involved in systemic inflammation and metabolic dysfunction in OSA are linked with accelerated cardiovascular morbidity.

Conditions

Sponsors & Collaborators

  • Instituto Aragones de Ciencias de la Salud

    collaborator OTHER_GOV

  • Hospital Miguel Servet

    collaborator OTHER

  • Aragon Institute of Health Sciences

    lead OTHER

Principal Investigators

  • Jose M Marin, M.D. · Hospital Miguel Servet

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2018-03-31
Completion
2019-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02131610 on ClinicalTrials.gov